Ligand profile
94H
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00051 — DNA gyrase subunit B
Identifiers
Database identifiers and provenance.
- Ligand ID
94H- PDB
5npk- UniProt (similar protein)
P66937- Target protein
- KP13_00051
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 83.8
- −1 ≤ LogP ≤ 5 3.72
- MW ≤ 500 Da 362.5
- LogP ≤ 5 3.72
- H-bond donors ≤ 5 3
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 83.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(cc1)[C@H](CN)NC(=O)c2cc(cs2)c3c[nH]c4c3cccn4c1ccc(cc1)[C@H](CN)NC(=O)c2cc(cs2)c3c[nH]c4c3cccn4
InChI=1S/C20H18N4OS/c21-10-17(13-5-2-1-3-6-13)24-20(25)18-9-14(12-26-18)16-11-23-19-15(16)7-4-8-22-19/h1-9,11-12,17H,10,21H2,(H,22,23)(H,24,25)/t17-/m0/s1InChI=1S/C20H18N4OS/c21-10-17(13-5-2-1-3-6-13)24-20(25)18-9-14(12-26-18)16-11-23-19-15(16)7-4-8-22-19/h1-9,11-12,17H,10,21H2,(H,22,23)(H,24,25)/t17-/m0/s1
ZNBOMXQVNVLXCZ-KRWDZBQOSA-NZNBOMXQVNVLXCZ-KRWDZBQOSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00521' 'PF00986' 'PF01751
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 94H →
- PDB RCSB structure 5npk →
- UniProt UniProt P66937 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “94H”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00051.
PDB 87
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 100
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).